-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ja0nA7TZ3qGfwR/JfXp0BJQHu3/+Pjw0nIDgdk0f9EjnSwSsfa/3kGSTYdgH/Wha ND890hgi8x8dPGjfKBb58g== 0001254316-05-000079.txt : 20050718 0001254316-05-000079.hdr.sgml : 20050718 20050718201027 ACCESSION NUMBER: 0001254316-05-000079 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050715 FILED AS OF DATE: 20050718 DATE AS OF CHANGE: 20050718 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENENTECH INC CENTRAL INDEX KEY: 0000318771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942347624 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 DNA WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-225-1000 MAIL ADDRESS: STREET 1: 1 DNA WAY STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EBERSMAN DAVID A CENTRAL INDEX KEY: 0001214123 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09813 FILM NUMBER: 05960364 MAIL ADDRESS: STREET 1: C/O GENENTECH INC STREET 2: 1 DNA WAY MS 49 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080-4990 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2005-07-15 0 0000318771 GENENTECH INC DNA 0001214123 EBERSMAN DAVID A 1 DNA WAY SO SAN FRANCISCO CA 94080 0 1 0 0 SR VP & CFO Common Stock 2005-07-15 4 M 0 62900 12.13 A 70089 D Common Stock 2005-07-15 4 S 0 62900 89.38 D 7189 D Common Stock 2005-07-15 4 M 0 380 12.13 A 7569 D Common Stock 2005-07-15 4 S 0 380 89.6 D 7189 D Non-Qualified Stock Option (right to buy) 12.13 2005-07-15 4 M 0 62900 0 D 1999-07-16 2009-07-16 Common Stock 62900 380 D Non-Qualified Stock Option (right to buy) 12.13 2005-07-15 4 M 0 380 0 D 1999-07-16 2009-07-16 Common Stock 380 0 D This stock option vests over three years in equal monthly increments beginning one month from grant date. This option may be immediately exercisable with the consent of Genentech. DAVID A. EBERSMAN 2005-07-18 -----END PRIVACY-ENHANCED MESSAGE-----